rs41265127
Positions:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_000751.3(CHRND):āc.862C>Gā(p.Gln288Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0031 in 1,613,830 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0023 ( 0 hom., cov: 31)
Exomes š: 0.0032 ( 11 hom. )
Consequence
CHRND
NM_000751.3 missense
NM_000751.3 missense
Scores
7
8
4
Clinical Significance
Conservation
PhyloP100: 7.87
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
PM1
In a transmembrane_region Helical (size 21) in uniprot entity ACHD_HUMAN there are 4 pathogenic changes around while only 1 benign (80%) in NM_000751.3
BP4
Computational evidence support a benign effect (MetaRNN=0.057361603).
BP6
Variant 2-232531393-C-G is Benign according to our data. Variant chr2-232531393-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 198749.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-232531393-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00231 (352/152110) while in subpopulation NFE AF= 0.00312 (212/67970). AF 95% confidence interval is 0.00277. There are 0 homozygotes in gnomad4. There are 158 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 11 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRND | NM_000751.3 | c.862C>G | p.Gln288Glu | missense_variant | 8/12 | ENST00000258385.8 | NP_000742.1 | |
CHRND | NM_001256657.2 | c.817C>G | p.Gln273Glu | missense_variant | 7/11 | NP_001243586.1 | ||
CHRND | NM_001311196.2 | c.559C>G | p.Gln187Glu | missense_variant | 8/12 | NP_001298125.1 | ||
CHRND | NM_001311195.2 | c.280C>G | p.Gln94Glu | missense_variant | 6/10 | NP_001298124.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRND | ENST00000258385.8 | c.862C>G | p.Gln288Glu | missense_variant | 8/12 | 1 | NM_000751.3 | ENSP00000258385 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00232 AC: 352AN: 151992Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
352
AN:
151992
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00265 AC: 667AN: 251240Hom.: 2 AF XY: 0.00253 AC XY: 343AN XY: 135806
GnomAD3 exomes
AF:
AC:
667
AN:
251240
Hom.:
AF XY:
AC XY:
343
AN XY:
135806
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00318 AC: 4646AN: 1461720Hom.: 11 Cov.: 33 AF XY: 0.00313 AC XY: 2274AN XY: 727150
GnomAD4 exome
AF:
AC:
4646
AN:
1461720
Hom.:
Cov.:
33
AF XY:
AC XY:
2274
AN XY:
727150
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00231 AC: 352AN: 152110Hom.: 0 Cov.: 31 AF XY: 0.00212 AC XY: 158AN XY: 74364
GnomAD4 genome
AF:
AC:
352
AN:
152110
Hom.:
Cov.:
31
AF XY:
AC XY:
158
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
10
ALSPAC
AF:
AC:
15
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
47
ExAC
AF:
AC:
305
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | CHRND: BS2 - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 25, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Mar 20, 2015 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 17, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Lethal multiple pterygium syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Congenital myasthenic syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
MVP
MPC
0.92
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at